FDA will ask outside experts to review Capricor’s therapy for Duchenne muscular dystrophy
Image Credit: STAT News

FDA will ask outside experts to review Capricor’s therapy for Duchenne muscular dystrophy

Watchdoq May 5, 2025
And other biotech updates, brought to you by The Readout.

Read Full Article